Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerOpenAI sign Language
VIPCreated with Sketch.

Rituximab monotherapy in mild pemphigus

Ali Nili,Hamidreza Mahmoudi, Nikta Heidari,Soheil Tavakolpour,Ali Salehi Farid,Kamran Balighi,Maryam Daneshpazhooh

JOURNAL OF DERMATOLOGICAL TREATMENT（2022）

Cited 1|Views2
No score
Abstract
Dear Editor,Rituximab (RTX), an anti-CD20+ agent, has been approved for the treatment of moderate-to-severe Pemphigus vulgaris (1,2). Based on the updated S2K guidelines on the management of pemphi...
More
Translated text
Key words
Pemphigus vulgaris,autoimmune bullous diseases,monotherapy,pemphigus foliaceus,rituximab
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined